Publication | Closed Access

Phase I–II study with docetaxel (D), cisplatin (C) and 5-fluorouracil (5-FU) in patients (pts) with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)

Malignant DiseaseMedicinePathologyHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyCancer ResearchMolecular OncologyPhase I–ii Study